(c) 2024 PillSync.com

tamsulosin hydrochloride 0.4 MG Modified Release Oral Capsule

1 INDICATIONS AND USAGE Tamsulosin hydrochloride capsules USP are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies ( 14 )]. Tamsulosin hydrochloride capsules USP are not indicated for the treatment of hypertension. Tamsulosin hydrochloride capsules USP are an alpha 1 adrenoceptor antagonist indicated for treatment of the signs and symptoms of benign prostatic hyperplasia ( 1 ) Tamsulosin hydrochloride capsules USP are not indicated for the treatment of hypertension ( 1 )

PD-Rx Pharmaceuticals, Inc.

FDA Reported Adverse Reactions
[1] drug ineffective    [2] nausea    [3] fatigue    [4] toxicity to various agents    [5] headache    [6] diarrhoea    [7] pain    [8] dyspnoea    [9] completed suicide    [10] vomiting   

10 years ago CAPSULE TSL 0 4 tamsulosin hydrochloride 0.4 MG Modified Release Oral Capsule

CAPSULE TSL 0 4

10 years ago CAPSULE TSL 0 4 tamsulosin hydrochloride 0.4 MG Modified Release Oral Capsule

TSL 0 4 CAPSULE

16 HOW SUPPLIED/STORAGE AND HANDLING

TAMSULOSIN HYDROCHLORIDE capsules USP 0.4 mg are supplied in high density polyethylene bottles containing 100 or 500 hard gelatin capsules with an olive green opaque cap and an orange opaque body. The cap is imprinted with the code “TSL 0.4” in black ink. (NDC 43063-264-30) Bottles of 30 (NDC 43063-264-90) Bottles of 90 (NDC 43063-264-01) Bottles of 100 Store at 25°C (77°F), excursions permitted to 15° - 30°C (59° - 86°F) [see USP Controlled Room Temperature]. Keep

TAMSULOSIN HYDROCHLORIDE capsules USP and all medicines out of reach of children.


More pills like CAPSULE TSL 0 4












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site